TYSABRI® (natalizumab) is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) to slow the worsening of symptoms common in people with MS and to decrease the number of flare-ups (relapses). MS is a progressive disease that causes damage to the central nervous system, manifested in outward and silent symptoms. Although there is no cure for MS, many treatments are available that can help slow progression of the disease.

Therapeutic Area

Relapsing forms of multiple sclerosis (MS)

Acquisition Date

Feb 2017